BibTex RIS Cite

Increased Sister Chromatid Exchanges in Patients with Gastrointestinal Cancers and in their First-Degree Relatives

Year 2014, , 94 - 98, 01.06.2014
https://doi.org/10.15197/sabad.1.11.46

Abstract

Gastrointestinal Cancers (GICs) are the most important causes of mortality and morbidity in industrialized world. Sister chromatid exchange (SCE), as an index of chromosomal instability, involves cancer. The aim of this study is to determine whether SCE frequency is a heritable factor for GIC or not. The study groups consisted of 15 gastrointestinal carcinoma patients, 13 patient relatives and 15 healthy subjects as the control group. After collection of 2 ml peripheral blood, lymphocytes were cultured for 3 days and sister chromatid exchange (SCE), mitotic index, and replication index were analyzed. SCE was significantly increased (p

References

  • Li L, Ying XJ, Sun TT, et al. Overview of Methodological Quality of Systematic Reviews about Gastric Cancer Risk and Protective Factors. Asian Pacific J Cancer Prev 2012; 13:2069-79.
  • Karaman A, Binici DN, Kabalar ME, Dursun H, Kurt A. Alteration of sister chromatid exchange frequencies in gastric cancer and chronic atrophic gastritis patients with and without H pyroli infection. World J Gastroenterol 2008; 14(16):2534-9.
  • Cao DX, Li ZJ, Jiang XO, et al. Osteopontin as potential biomarker and therapeutic target in gastric and liver can- cers. World J Gastroenterol 2012; 18(30):3923-30.
  • Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007; 447(7143): 433-40.
  • Lansdorp PM, Falconer E, Tao J, Brind'Amour J, Naumann U. Epigenetic differences between sisters chromatids? Ann N Y Acad Sci 2012;1266:1-6.
  • Bonassi S, Lando C, Ceppi M, Landi S, Rossi AM, Barale R. No association between increased levels of high-frequen- cy sister chromatid exchange cells (HFCs) and the risk of cancer in healthy individuals. Environ Mol Mutagen 2004; 43(2):134-6. P+ 0.001** 0.002** 0.001** RPI
  • +Kruskal Wallis Test 7.15 ± 2.15 1.70 ± 0.21 9.00 ± 2.26 2.04 ± 1.13
  • **p<0.01 advanced significant

Increased Sister Chromatid Exchanges in Patients with Gastrointestinal Cancers and in their First-Degree Relatives

Year 2014, , 94 - 98, 01.06.2014
https://doi.org/10.15197/sabad.1.11.46

Abstract

Gastrointestinal kanserler, sanayileşmiş ülkelerdeki mortalite ve morbiditenin en önemli sebeplerinden biridir. Kromozomal kararsızlığın ölçüsü olan kardeş kromatid değişimi (KKD) kanser etiyolojisinde yer almaktadır. Bu çalışmanın amacı, kardeş kromatid değişim sıklığının gastrointestinal kanserde kalıtsal bir faktör olup olmadığının araştırılmasıdır. Çalışma grupları 15 gastrointestinal kanser hastası ve 13 hasta yakını, kontrol grubu ise 15 sağlıklı bireyden oluşmaktadır. Olgulardan 2 ml periferik kan alındıktan sonra lenfositler 3 gün süreyle kültüre edildikten sonra, kardeş kromatid değişimi, mitotik indeks ve replikasyon indeksi analiz edildi. Kardeş kromatid değişimi açısından hasta (16,06±22,37) ve hasta yakınları (5,23±2,64) grubunda kontrol grubuna (3,51±1,58) göre istatistiksel olarak anlamlı bir artış gözlemdi (p<0,01). Hasta grubunun (5,4±3,13) mitotik indeksi hasta yakınları (7,15±2,15) ve kontrol grubuna (9,00±2,26) göre anlamlı derecede düşük çıkmıştır (p<0,05, p<0,01). Benzer olarak hasta grubunun replikasyon indeksi (1,39±0,35), hasta yakınları (1,7±0,21) ve kontrol grubuna (2,04±1,13) göre anlamlı derecede düşük çıkmıştır (p<0,01). Elde edilen sonuçlar kardeş kromatid değişiminin gastrointestinal kanserler için kalıtsal bir faktör olduğunu göstermektedir. Artan kardeş kromatid değişimi, karsinogenezde etken olduğu bilinen genomik kararsızlığın ölçüsüdür. Fakat genomik kararsızlığın başlıca sebepleri arasında epigenetik değişiklikler olduğundan, epigenetik değişikliklerle kombine daha ileri araştırmaların yapılması gerekmektedir

References

  • Li L, Ying XJ, Sun TT, et al. Overview of Methodological Quality of Systematic Reviews about Gastric Cancer Risk and Protective Factors. Asian Pacific J Cancer Prev 2012; 13:2069-79.
  • Karaman A, Binici DN, Kabalar ME, Dursun H, Kurt A. Alteration of sister chromatid exchange frequencies in gastric cancer and chronic atrophic gastritis patients with and without H pyroli infection. World J Gastroenterol 2008; 14(16):2534-9.
  • Cao DX, Li ZJ, Jiang XO, et al. Osteopontin as potential biomarker and therapeutic target in gastric and liver can- cers. World J Gastroenterol 2012; 18(30):3923-30.
  • Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007; 447(7143): 433-40.
  • Lansdorp PM, Falconer E, Tao J, Brind'Amour J, Naumann U. Epigenetic differences between sisters chromatids? Ann N Y Acad Sci 2012;1266:1-6.
  • Bonassi S, Lando C, Ceppi M, Landi S, Rossi AM, Barale R. No association between increased levels of high-frequen- cy sister chromatid exchange cells (HFCs) and the risk of cancer in healthy individuals. Environ Mol Mutagen 2004; 43(2):134-6. P+ 0.001** 0.002** 0.001** RPI
  • +Kruskal Wallis Test 7.15 ± 2.15 1.70 ± 0.21 9.00 ± 2.26 2.04 ± 1.13
  • **p<0.01 advanced significant
There are 8 citations in total.

Details

Primary Language English
Journal Section Original Articles
Authors

Taner Turgut This is me

Mehmet Yaşar This is me

Kürşat Oğuz Yaykaşlı This is me

Ertuğrul Ertaş This is me

Fatma Sılan This is me

Publication Date June 1, 2014
Published in Issue Year 2014

Cite

APA Turgut, T., Yaşar, M., Yaykaşlı, K. O., Ertaş, E., et al. (2014). Increased Sister Chromatid Exchanges in Patients with Gastrointestinal Cancers and in their First-Degree Relatives. European Journal of General Medicine, 11(2), 94-98. https://doi.org/10.15197/sabad.1.11.46
AMA Turgut T, Yaşar M, Yaykaşlı KO, Ertaş E, Sılan F. Increased Sister Chromatid Exchanges in Patients with Gastrointestinal Cancers and in their First-Degree Relatives. European Journal of General Medicine. June 2014;11(2):94-98. doi:10.15197/sabad.1.11.46
Chicago Turgut, Taner, Mehmet Yaşar, Kürşat Oğuz Yaykaşlı, Ertuğrul Ertaş, and Fatma Sılan. “Increased Sister Chromatid Exchanges in Patients With Gastrointestinal Cancers and in Their First-Degree Relatives”. European Journal of General Medicine 11, no. 2 (June 2014): 94-98. https://doi.org/10.15197/sabad.1.11.46.
EndNote Turgut T, Yaşar M, Yaykaşlı KO, Ertaş E, Sılan F (June 1, 2014) Increased Sister Chromatid Exchanges in Patients with Gastrointestinal Cancers and in their First-Degree Relatives. European Journal of General Medicine 11 2 94–98.
IEEE T. Turgut, M. Yaşar, K. O. Yaykaşlı, E. Ertaş, and F. Sılan, “Increased Sister Chromatid Exchanges in Patients with Gastrointestinal Cancers and in their First-Degree Relatives”, European Journal of General Medicine, vol. 11, no. 2, pp. 94–98, 2014, doi: 10.15197/sabad.1.11.46.
ISNAD Turgut, Taner et al. “Increased Sister Chromatid Exchanges in Patients With Gastrointestinal Cancers and in Their First-Degree Relatives”. European Journal of General Medicine 11/2 (June 2014), 94-98. https://doi.org/10.15197/sabad.1.11.46.
JAMA Turgut T, Yaşar M, Yaykaşlı KO, Ertaş E, Sılan F. Increased Sister Chromatid Exchanges in Patients with Gastrointestinal Cancers and in their First-Degree Relatives. European Journal of General Medicine. 2014;11:94–98.
MLA Turgut, Taner et al. “Increased Sister Chromatid Exchanges in Patients With Gastrointestinal Cancers and in Their First-Degree Relatives”. European Journal of General Medicine, vol. 11, no. 2, 2014, pp. 94-98, doi:10.15197/sabad.1.11.46.
Vancouver Turgut T, Yaşar M, Yaykaşlı KO, Ertaş E, Sılan F. Increased Sister Chromatid Exchanges in Patients with Gastrointestinal Cancers and in their First-Degree Relatives. European Journal of General Medicine. 2014;11(2):94-8.